Kobayashi Pharmaceutical decides to resign as president and chairman - in response to the Red Koji issue

Updated 2024/7/23 12:42 (some excerpts)
Part of executive remuneration is voluntarily returned, President Akihiro is 50% of monthly remuneration, and managing director is 40%
After the beginning of February, the entire company should have dealt with it as soon as possible - investigation report
Kobayashi Pharmaceutical announced personnel affairs on the 23rd that Chairman Kobayashi Kazumasa and President Kobayashi Akihiro will resign. Chairman Kazumasa also resigns as a director and becomes a special adviser, and President Akihiro is in charge of director compensation. Senior Managing Director Satoshi Yamane will be promoted to the successor president on 8/8.
　　A partial voluntary return of executive remuneration was also announced. President Akihiro will return 50% of the monthly remuneration, and Managing Director Yamane will return 40%. The target period is half a year until 2024/6.